PHIOGEN Trademark

Trademark Overview


On Wednesday, August 31, 2022, a trademark application was filed for PHIOGEN with the United States Patent and Trademark Office. The USPTO has given the PHIOGEN trademark a serial number of 97979443. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, February 19, 2025. This trademark is owned by Baylor College of Medicine. The PHIOGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of therapeutic bacteriophage cocktail compositions and related bacteriophage research and development services; pharmaceutical research and development for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders using bacteriophages; pharmaceutical research in the field of engineered bacteriophage; scientific research, namely, research relating to bacteriophage platforms and bacteriophages for use in connection with a wide variety of therapeutic agents; scientific and technical consulting services relating to producing, assaying, and purifying bacteriophages found in humans and animals
phiogen

General Information


Serial Number97979443
Word MarkPHIOGEN
Filing DateWednesday, August 31, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, February 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and ServicesDevelopment of therapeutic bacteriophage cocktail compositions and related bacteriophage research and development services; pharmaceutical research and development for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders using bacteriophages; pharmaceutical research in the field of engineered bacteriophage; scientific research, namely, research relating to bacteriophage platforms and bacteriophages for use in connection with a wide variety of therapeutic agents; scientific and technical consulting services relating to producing, assaying, and purifying bacteriophages found in humans and animals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 19, 2022
Primary Code042
First Use Anywhere DateWednesday, May 31, 2023
First Use In Commerce DateWednesday, May 31, 2023

Trademark Owner History


Party NameBaylor College of Medicine
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHouston, TX 77030

Party NameBaylor College of Medicine
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHouston, TX 77030

Trademark Events


Event DateEvent Description
Saturday, September 3, 2022NEW APPLICATION ENTERED
Monday, September 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 16, 2023ASSIGNED TO EXAMINER
Sunday, June 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 19, 2024SOU EXTENSION 1 FILED
Tuesday, March 19, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 19, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024USE AMENDMENT FILED
Wednesday, September 4, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, September 4, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, September 4, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, November 19, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 19, 2025DIVISIONAL PROCESSING COMPLETE
Wednesday, February 19, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 19, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 19, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 19, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL